{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:18:47Z","timestamp":1790565527815,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70036-8","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:35:35Z","timestamp":1772472935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses"],"prefix":"10.1038","volume":"17","author":[{"given":"Saya","family":"Moriyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"di Iulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Zatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector E.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha V.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Czudnochowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3384-7414","authenticated-orcid":false,"given":"Eita","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-1671","authenticated-orcid":false,"given":"Ryutaro","family":"Kotaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eneida","family":"Vetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cyrus Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shirakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-2297","authenticated-orcid":false,"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-4087","authenticated-orcid":false,"given":"Yoshimasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-1364","authenticated-orcid":false,"given":"Davide","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5776-654X","authenticated-orcid":false,"given":"Matteo Samuele","family":"Pizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"70036_CR1","doi-asserted-by":"publisher","first-page":"e2099","DOI":"10.1002\/rmv.2099","volume":"30","author":"R Yamaji","year":"2020","unstructured":"Yamaji, R. et al. Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses. Rev. Med. Virol. 30, e2099 (2020).","journal-title":"Rev. Med. Virol."},{"key":"70036_CR2","doi-asserted-by":"publisher","first-page":"eadj2379","DOI":"10.1126\/scitranslmed.adj2379","volume":"15","author":"DM Morens","year":"2023","unstructured":"Morens, D. M., Park, J. & Taubenberger, J. K. Many potential pathways to future pandemic influenza. Sci. Transl. Med. 15, eadj2379 (2023).","journal-title":"Sci. Transl. Med."},{"key":"70036_CR3","doi-asserted-by":"publisher","first-page":"e1000161","DOI":"10.1371\/journal.ppat.1000161","volume":"4","author":"D Vijaykrishna","year":"2008","unstructured":"Vijaykrishna, D. et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog. 4, e1000161 (2008).","journal-title":"PLoS Pathog."},{"key":"70036_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2155072","volume":"12","author":"J Shi","year":"2023","unstructured":"Shi, J., Zeng, X., Cui, P., Yan, C. & Chen, H. Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg. Microbes Infect. 12, 2155072 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"70036_CR5","unstructured":"(WHO), W. H. O. Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003-2024, https:\/\/www.who.int\/publications\/m\/item\/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who--2003-2024-28-march-2024 (2024)."},{"key":"70036_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3201\/eid3003.231098","volume":"30","author":"PI Plaza","year":"2024","unstructured":"Plaza, P. I., Gamarra-Toledo, V., Eugui, J. R. & Lambertucci, S. A. Recent changes in patterns of mammal infection with highly pathogenic avian influenza A(H5N1) virus worldwide. Emerg. Infect. Dis. 30, 444\u2013452 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"70036_CR7","doi-asserted-by":"publisher","first-page":"e1011214","DOI":"10.1371\/journal.ppat.1011214","volume":"19","author":"JY Siegers","year":"2023","unstructured":"Siegers, J. Y. et al. Evolution of highly pathogenic H5N1 influenza A virus in the central nervous system of ferrets. PLoS Pathog. 19, e1011214 (2023).","journal-title":"PLoS Pathog."},{"key":"70036_CR8","doi-asserted-by":"publisher","first-page":"14063","DOI":"10.1073\/pnas.0900096106","volume":"106","author":"H Jang","year":"2009","unstructured":"Jang, H. et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc. Natl. Acad. Sci. USA. 106, 14063\u201314068 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70036_CR9","unstructured":"Marion P. G. et al. The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b., https:\/\/cdn.who.int\/media\/docs\/default-source\/one-health\/ohhlep\/panzootic-spread-of-highly-pathogenic-avian-influenza.pdf?sfvrsn=205b68bd_14&download=true (2023)."},{"key":"70036_CR10","doi-asserted-by":"publisher","unstructured":"Aguero, M. et al. Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.3.2300001 (2023)","DOI":"10.2807\/1560-7917.ES.2023.28.3.2300001"},{"key":"70036_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3201\/eid1105.050007","volume":"11","author":"R Thanawongnuwech","year":"2005","unstructured":"Thanawongnuwech, R. et al. Probable tiger-to-tiger transmission of avian influenza H5N1. Emerg. Infect. Dis. 11, 699\u2013701 (2005).","journal-title":"Emerg. Infect. Dis."},{"key":"70036_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41182-0","volume":"14","author":"M Leguia","year":"2023","unstructured":"Leguia, M. et al. Highly pathogenic avian influenza A (H5N1) in marine mammals and seabirds in Peru. Nat. Commun. 14, 5489 (2023).","journal-title":"Nat. Commun."},{"key":"70036_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2186608","volume":"12","author":"TN Alkie","year":"2023","unstructured":"Alkie, T. N. et al. Characterization of neurotropic HPAI H5N1 viruses with novel genome constellations and mammalian adaptive mutations in free-living mesocarnivores in Canada. Emerg. Microbes Infect. 12, 2186608 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"70036_CR14","unstructured":"Prevention, C. F. D. C. A. Technical Report: Highly Pathogenic Avian Influenza A(H5N1) Viruses, https:\/\/www.cdc.gov\/flu\/avianflu\/spotlights\/2023-2024\/h5n1-technical-report_april-2024.htm (2024)."},{"key":"70036_CR15","doi-asserted-by":"publisher","unstructured":"Uyeki, T. M. et al. Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc2405371 (2024).","DOI":"10.1056\/NEJMc2405371"},{"key":"70036_CR16","doi-asserted-by":"publisher","unstructured":"Garg, S. et al. Highly pathogenic avian influenza A(H5N1) virus infections in humans. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2414610 (2024).","DOI":"10.1056\/NEJMoa2414610"},{"key":"70036_CR17","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD de Jong","year":"2005","unstructured":"de Jong, M. D. et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353, 2667\u20132672 (2005).","journal-title":"N. Engl. J. Med"},{"key":"70036_CR18","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3201\/eid1309.070164","volume":"13","author":"JL McKimm-Breschkin","year":"2007","unstructured":"McKimm-Breschkin, J. L., Selleck, P. W., Usman, T. B. & Johnson, M. A. Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg. Infect. Dis. 13, 1354\u20131357 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"70036_CR19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14760584.2021.1964961","volume":"20","author":"I Isakova-Sivak","year":"2021","unstructured":"Isakova-Sivak, I. et al. Influenza vaccine: progress in a vaccine that elicits a broad immune response. Expert Rev. Vaccines 20, 1097\u20131112 (2021).","journal-title":"Expert Rev. Vaccines"},{"key":"70036_CR20","doi-asserted-by":"publisher","first-page":"eade4790","DOI":"10.1126\/scitranslmed.ade4790","volume":"15","author":"AT Widge","year":"2023","unstructured":"Widge, A. T. et al. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Sci. Transl. Med. 15, eade4790 (2023).","journal-title":"Sci. Transl. Med"},{"key":"70036_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S1473-3099(22)00056-1","volume":"22","author":"I Isakova-Sivak","year":"2022","unstructured":"Isakova-Sivak, I. & Rudenko, L. The future of haemagglutinin stalk-based universal influenza vaccines. Lancet Infect. Dis. 22, 926\u2013928 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"70036_CR22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa055778","volume":"354","author":"JJ Treanor","year":"2006","unstructured":"Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T. & Wolff, M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N. Engl. J. Med. 354, 1343\u20131351 (2006).","journal-title":"N. Engl. J. Med"},{"key":"70036_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.vaccine.2018.11.069","volume":"37","author":"CM Oshansky","year":"2019","unstructured":"Oshansky, C. M. et al. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). Vaccine 37, 435\u2013443 (2019).","journal-title":"Vaccine"},{"key":"70036_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55546-7","volume":"16","author":"DW Hawman","year":"2025","unstructured":"Hawman, D. W. et al. Clade 2.3.4.4b, but not historical clade 1 HA, replicating RNA vaccine protects against bovine H5N1 challenge in mice. Nat. Commun. 16, 655 (2025).","journal-title":"Nat. Commun."},{"key":"70036_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-023-06136-y","volume":"618","author":"C Momont","year":"2023","unstructured":"Momont, C. et al. A pan-influenza antibody inhibiting neuraminidase via receptor mimicry. Nature 618, 590\u2013597 (2023).","journal-title":"Nature"},{"key":"70036_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-1759(90)90255-T","volume":"135","author":"CR Lambre","year":"1990","unstructured":"Lambre, C. R., Terzidis, H., Greffard, A. & Webster, R. G. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J. Immunol. Methods 135, 49\u201357 (1990).","journal-title":"J. Immunol. Methods"},{"key":"70036_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.immuni.2024.02.003","volume":"57","author":"J Lederhofer","year":"2024","unstructured":"Lederhofer, J. et al. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase. Immunity 57, 574\u2013586 e577 (2024).","journal-title":"Immunity"},{"key":"70036_CR28","doi-asserted-by":"publisher","first-page":"e1002068","DOI":"10.1371\/journal.ppat.1002068","volume":"7","author":"Y Watanabe","year":"2011","unstructured":"Watanabe, Y. et al. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog. 7, e1002068 (2011).","journal-title":"PLoS Pathog."},{"key":"70036_CR29","doi-asserted-by":"publisher","unstructured":"Watanabe, Y. et al. Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients. mBio https:\/\/doi.org\/10.1128\/mBio.00081-15 (2015).","DOI":"10.1128\/mBio.00081-15"},{"key":"70036_CR30","doi-asserted-by":"publisher","unstructured":"Burrough, E. R. et al. Highly pathogenic avian influenza A(H5N1) Clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg. Infect. Dis. https:\/\/doi.org\/10.3201\/eid3007.240508 (2024).","DOI":"10.3201\/eid3007.240508"},{"key":"70036_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1056\/NEJMe2416323","volume":"392","author":"MG Ison","year":"2025","unstructured":"Ison, M. G. & Marrazzo, J. The emerging threat of H5N1 to human health. N. Engl. J. Med. 392, 916\u2013918 (2025).","journal-title":"N. Engl. J. Med"},{"key":"70036_CR32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s42003-024-06173-x","volume":"7","author":"A Murawski","year":"2024","unstructured":"Murawski, A. et al. Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida. Commun. Biol. 7, 476 (2024).","journal-title":"Commun. Biol."},{"key":"70036_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2469643","volume":"14","author":"AV Signore","year":"2025","unstructured":"Signore, A. V. et al. Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024. Emerg. Microbes Infect. 14, 2469643 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"70036_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.virol.2016.10.024","volume":"500","author":"I Kosik","year":"2017","unstructured":"Kosik, I. & Yewdell, J. W. Influenza A virus hemagglutinin-specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms. Virology 500, 178\u2013183 (2017).","journal-title":"Virology"},{"key":"70036_CR35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"70036_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1021\/ct050183l","volume":"2","author":"R Geney","year":"2006","unstructured":"Geney, R., Layten, M., Gomperts, R., Hornak, V. & Simmerling, C. Investigation of salt bridge stability in a generalized born solvent model. J. Chem. Theory Comput. 2, 115\u2013127 (2006).","journal-title":"J. Chem. Theory Comput."},{"key":"70036_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06617-0","volume":"622","author":"NN Thadani","year":"2023","unstructured":"Thadani, N. N. et al. Learning from prepandemic data to forecast viral escape. Nature 622, 818\u2013825 (2023).","journal-title":"Nature"},{"key":"70036_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","volume":"98","author":"M Samson","year":"2013","unstructured":"Samson, M., Pizzorno, A., Abed, Y. & Boivin, G. Influenza virus resistance to neuraminidase inhibitors. Antivir. Res. 98, 174\u2013185 (2013).","journal-title":"Antivir. Res."},{"key":"70036_CR39","doi-asserted-by":"publisher","first-page":"eabk3445","DOI":"10.1126\/scitranslmed.abk3445","volume":"14","author":"MC Maher","year":"2022","unstructured":"Maher, M. C. et al. Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Sci. Transl. Med. 14, eabk3445 (2022).","journal-title":"Sci. Transl. Med."},{"key":"70036_CR40","doi-asserted-by":"publisher","unstructured":"Graziosi, G., Lupini, C., Catelli, E. & Carnaccini, S. Highly Pathogenic Avian Influenza (HPAI) H5 clade 2.3.4.4b virus infection in birds and mammals. Animals https:\/\/doi.org\/10.3390\/ani14091372 (2024).","DOI":"10.3390\/ani14091372"},{"key":"70036_CR41","doi-asserted-by":"publisher","unstructured":"Verhagen, J. H., Fouchier, R. A. M. & Lewis, N. Highly Pathogenic avian influenza viruses at the wild-domestic bird interface in Europe: future directions for research and surveillance. Viruses https:\/\/doi.org\/10.3390\/v13020212 (2021).","DOI":"10.3390\/v13020212"},{"key":"70036_CR42","doi-asserted-by":"publisher","unstructured":"Nguyen, T.-Q. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle. 388, eadq0900 bioRxiv. https:\/\/doi.org\/10.1126\/science.adq0900 (2025).","DOI":"10.1126\/science.adq0900"},{"key":"70036_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-024-08254-7","volume":"636","author":"C Gu","year":"2024","unstructured":"Gu, C. et al. A human isolate of bovine H5N1 is transmissible and lethal in animal models. Nature 636, 711\u2013718 (2024).","journal-title":"Nature"},{"key":"70036_CR44","doi-asserted-by":"publisher","unstructured":"Swierczynska, M., Mirowska-Guzel, D. M. & Pindelska, E. Antiviral drugs in influenza. Int. J. Environ. Res. Public Health https:\/\/doi.org\/10.3390\/ijerph19053018 (2022).","DOI":"10.3390\/ijerph19053018"},{"key":"70036_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMp1714916","volume":"378","author":"CI Paules","year":"2018","unstructured":"Paules, C. I., Sullivan, S. G., Subbarao, K. & Fauci, A. S. Chasing seasonal influenza - the need for a universal influenza vaccine. N. Engl. J. Med. 378, 7\u20139 (2018).","journal-title":"N. Engl. J. Med"},{"key":"70036_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","volume":"39","author":"C Henry","year":"2018","unstructured":"Henry, C., Palm, A. E., Krammer, F. & Wilson, P. C. From original antigenic sin to the universal influenza virus vaccine. Trends Immunol. 39, 70\u201379 (2018).","journal-title":"Trends Immunol."},{"key":"70036_CR47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/infdis\/jix292","volume":"216","author":"CI Paules","year":"2017","unstructured":"Paules, C. I. et al. The hemagglutinin a stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses. J. Infect. Dis. 216, 356\u2013365 (2017).","journal-title":"J. Infect. Dis."},{"key":"70036_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","volume":"166","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell 166, 609\u2013623 (2016).","journal-title":"Cell"},{"key":"70036_CR49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.aay0678","volume":"366","author":"D Stadlbauer","year":"2019","unstructured":"Stadlbauer, D. et al. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366, 499\u2013504 (2019).","journal-title":"Science"},{"key":"70036_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34521-0","volume":"13","author":"A Yasuhara","year":"2022","unstructured":"Yasuhara, A. et al. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases. Nat. Commun. 13, 6602 (2022).","journal-title":"Nat. Commun."},{"key":"70036_CR51","doi-asserted-by":"publisher","first-page":"12274","DOI":"10.1128\/JVI.76.23.12274-12280.2002","volume":"76","author":"U Gulati","year":"2002","unstructured":"Gulati, U. et al. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A\/Memphis\/31\/98). J. Virol. 76, 12274\u201312280 (2002).","journal-title":"J. Virol."},{"key":"70036_CR52","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1073\/pnas.87.2.786","volume":"87","author":"ED Kilbourne","year":"1990","unstructured":"Kilbourne, E. D., Johansson, B. E. & Grajower, B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl. Acad. Sci. USA. 87, 786\u2013790 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70036_CR53","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1099\/vir.0.043059-0","volume":"93","author":"KB Westgeest","year":"2012","unstructured":"Westgeest, K. B. et al. Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution. J. Gen. Virol. 93, 1996\u20132007 (2012).","journal-title":"J. Gen. Virol."},{"key":"70036_CR54","doi-asserted-by":"publisher","unstructured":"Krammer, F. et al. NAction! how can neuraminidase-based immunity contribute to better influenza virus vaccines? mBio 9, https:\/\/doi.org\/10.1128\/mBio.02332-17 (2018).","DOI":"10.1128\/mBio.02332-17"},{"key":"70036_CR55","unstructured":"World Health Organization., W. G. I. S. N. Manual for the laboratory diagnosis and virological surveillance of influenza. (2011)."},{"key":"70036_CR56","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"70036_CR57","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1021\/jp8001614","volume":"112","author":"IS Joung","year":"2008","unstructured":"Joung, I. S. & Cheatham, T. E. 3rd. Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J. Phys. Chem. B 112, 9020\u20139041 (2008).","journal-title":"J. Phys. Chem. B"},{"key":"70036_CR58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"70036_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"70036_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"70036_CR61","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.str.2018.09.006","volume":"27","author":"B Frenz","year":"2019","unstructured":"Frenz, B. et al. Automatically fixing errors in glycoprotein structures with rosetta. Structure 27, 134\u2013139 e133 (2019).","journal-title":"Structure"},{"key":"70036_CR62","doi-asserted-by":"publisher","unstructured":"Wang, R. Y. et al. Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta. Elife https:\/\/doi.org\/10.7554\/eLife.17219 (2016).","DOI":"10.7554\/eLife.17219"},{"key":"70036_CR63","unstructured":"Schr\u00f6dinger, L. D. W. PyMOL. Retrieved from http:\/\/www.pymol.org\/pymol, 2020)."},{"key":"70036_CR64","unstructured":"Case D. A. et al., Amber 2022, (University of California, San Francisco, 2022)."},{"key":"70036_CR65","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput"},{"key":"70036_CR66","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jcc.20820","volume":"29","author":"KN Kirschner","year":"2008","unstructured":"Kirschner, K. N. et al. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29, 622\u2013655 (2008).","journal-title":"J. Comput. Chem."},{"key":"70036_CR67","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1126\/science.abo7896","volume":"377","author":"TN Starr","year":"2022","unstructured":"Starr, T. N. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 377, 420\u2013424 (2022).","journal-title":"Science"},{"key":"70036_CR68","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/jcc.25382","volume":"39","author":"DR Roe","year":"2018","unstructured":"Roe, D. R. & Cheatham, T. E. 3rd. Parallelization of CPPTRAJ enables large-scale analysis of molecular dynamics trajectory data. J. Comput. Chem. 39, 2110\u20132117 (2018).","journal-title":"J. Comput. Chem."},{"key":"70036_CR69","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","volume":"379","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 379, 1123\u20131130 (2023).","journal-title":"Science"},{"key":"70036_CR70","doi-asserted-by":"publisher","unstructured":"Chloe, H. R. et al. Learning Inverse Folding from Millions of Predicted Structures. bioRxiv https:\/\/doi.org\/10.1101\/2022.04.10.487779 (2022).","DOI":"10.1101\/2022.04.10.487779"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70036-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:05:06Z","timestamp":1775743506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70036-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70036"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70036-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5999144\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.D.I., F.Z., K.H., H.E.M., J.M.E., H.V.D., N.C., A.C., Y.C., A.P., E.V., M.C.M., L.E.R., G.S., D.C, and M.S.P. are current or former employees of and may hold shares in Vir Biotechnology Inc. M.S.P., D.C., and G.S. are currently listed as inventors on patent applications, which disclose the subject matter described in this manuscript. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3351"}}